Abstract
305P A real-world multicenter cohort study of lenvatinib (LEN) plus pembrolizumab (PEM) in Japanese patients with endometrial cancer: Interim analysis of GOGO-EM4 study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have